- Efficacy and safety of ixekizumab in a randomized, double-blinded, pl…
Number of the records: 1  

Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled, phase 3b clinical trial in patients with moderate-to-severe genital psoriasis

  1. RYAN, Caitriona. Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled, phase 3b clinical trial in patients with moderate-to-severe genital psoriasis. In Dermatológia pre prax. ISSN 1337-1746. Bratislava : SOLEN, 2018, 2018, roč. 12, č. 3, s. 147.
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.